宮嶋ちはる

Chiharu Miyajima

所属機関・部署：

研究分野 (1件)：細胞生物学

競争的資金等の研究課題 (2件)：

論文 (16件)：

Mai Nagasaka, Chiharu Miyajima, Yasumichi Inoue, Sakura Hashiguchi, Yuya Suzuki, Daisuke Morishita, Hiromasa Aoki, Kohki Toriuchi, Ryohei Katayama, Mineyoshi Aoyama, et al. ID3 is a novel target gene of p53 and modulates lung cancer cell metastasis. Biochemical and Biophysical Research Communications. 2024. 149789-149789
Mai Nagasaka, Yasumichi Inoue, Yuji Nagao, Chiharu Miyajima, Daisuke Morishita, Hiromasa Aoki, Mineyoshi Aoyama, Takeshi Imamura, Hidetoshi Hayashi. SET8 is a novel negative regulator of TGF-β signaling in a methylation-independent manner. Scientific Reports. 2023. 13. 1
Muneshige Tokugawa, Yasumichi Inoue, Hiromasa Aoki, Chiharu Miyajima, Kan'ichiro Ishiuchi, Kento Tsurumi, Chisane Kujirai, Daisuke Morishita, Michiyo Matsuno, Hajime Mizukami, et al. Involvement of cardiac glycosides targeting Na/K-ATPase in their inhibitory effects on c-Myc expression via its transcription, translation, and proteasomal degradation. Journal of biochemistry. 2023
Mai Nagasaka, Chiharu Miyajima, Hiromasa Aoki, Mineyoshi Aoyama, Daisuke Morishita, Yasumichi Inoue, Hidetoshi Hayashi. Insights into Regulators of p53 Acetylation. Cells. 2022. 11. 23. 3825-3825
Chiharu Miyajima, Yurika Hayakawa, Yasumichi Inoue, Mai Nagasaka, Hidetoshi Hayashi. HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ. Pharmaceuticals (Basel, Switzerland). 2022. 15. 8

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

宮嶋 ちはる